無針薬物送達技術の世界市場予測2016-2026

◆英語タイトル:Needle-Free Delivery Technology Market Forecast 2016-2026
◆商品コード:VGAIN60906
◆発行会社(調査会社):visiongain
◆発行日:2016年8月
◆ページ数:183
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Sigle User(1名利用)GBP1,999 ⇒換算¥291,854見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥437,854見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥729,854見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongain社の日本における正規販売代理店です。visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、無針薬物送達技術の世界市場について調査・分析し、無針薬物送達技術の世界市場規模、市場動向、市場予測、市場環境分析、専門家の見解、関連企業情報などを含め、以下の構成でお届けいたします。
1. レポート概要

2. 無針薬物送達技術の概要

3. 無針薬物送達技術の世界市場2016-2026

4. ジェット式注射器技術市場2016-2026

5. 無針薬物送達技術の競合市場2016-2026

6. 主要国市場2016-2026

7. 無針薬物送達技術市場における主要企業

8. 無針薬物送達技術市場の定性分析

9. 結論

10. 用語集
【レポートの概要】

What can be expected from the Needle-Free Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.

Our 183-page report provides 105 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national Needle-Free Delivery Technology markets. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

See revenue forecasts for the leading regional and national markets
How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:
• US
• EU5 (Germany, France, UK, Italy and Spain)
• Japan
• China
• India
• Rest of the World

Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Needle-Free Delivery Technologies Market will reach $2,093.9m in 2020. We predict high revenue growth over the forecast period, which will driven by the strong demand for improved vaccine and drug delivery methods.

Our work analyses the key companies in the market. See visiongain’s analysis of six leading companies, including:
• 3M
• Antares Pharma
• Beckton Dickinson and Company (BD)
• Bioject Medical Technologies
• PharmaJet
• Zogenix

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook including regional and national revenue shares
• Historic revenue, analysis and discussion of company performance
• Analysis of major products/services currently available on the market
• Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the needle-free drug delivery industry?
Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
• Future opportunities for needle-free delivery technologies

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M report helps you
In summary, our 183-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Needle-Free Delivery Technology Market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for two major submarkets – jet injectors and competing technologies (novel needle technology, inhaler technology and transdermal patch technology)
• Revenue forecasts to 2026 for two major regional markets – EU5 and Rest of the World
• Revenue forecasts to 2026 for the leading national markets – US, Germany, France, UK, Italy, Spain, Japan, China, India and Rest of the World
• Assessment of leading companies – analysis of services, business operations, products, pipelines, revenue (where available) and recent mergers & acquisition activity
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the needle-free drug delivery market and leading companies. You will find data, trends and predictions. Please order our report now.

【レポートの目次】

1. Report Overview
1.1 Global Needle-Free Delivery Technology Market Overview
1.2 Global Needle-Free Delivery Technology Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Needle-Free Delivery Technology
2.1 What is Needle-Free Delivery Technology?
2.1.1 Needlestick Injury
2.1.1.1 Blood-Borne Pathogens and Needlestick Injury
2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem
2.2 The Needle-Free Delivery Technology Market
2.2.1 Jet Injectors
2.2.1.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs)
2.2.1.2 Strengths and Weaknesses of Jet Injectors
2.2.2 Competing Needle-Free Technologies
2.2.2.1 Novel Needle Technology
2.2.2.2 Pen Needles
2.2.2.3 Microneedles
2.2.2.4 Hollow Microneedles
2.2.2.5 Solid Coated Microneedles
2.2.2.6 Solid Biodegradable Microneedles
2.2.2.7 Solid Uncoated Microneedles
2.2.2.8 Using the Right Microneedles
2.2.2.9 Inhaler Technology
2.2.2.10 Transdermal Patch Technology
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
2.3.1 Pain Management
2.3.1.1 Using Needle-Free Injection Devices to Administer Lidocaine
2.3.2 Vaccine Delivery: Improving Immune Response
2.3.2.1 Needle-Free Vaccine Delivery
2.3.2.2 Mass Immunisation
2.3.3 Insulin Delivery for Diabetics
2.3.4 Paediatric Injections
2.3.5 Other Uses for Needle-Free Injection Technology
2.4 Regulation of the Needle-Free Delivery Technology Market
2.4.1 The US Regulation System
2.4.1.1 Combination Products
2.4.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices
2.4.2 The European Regulation System
2.4.2.1 Post Marketing Surveillance in the EU
2.5 Biopharmaceuticals
2.5.1 An Introduction to the Biological Drugs Market
2.5.2 Biologics: A Rising Drugs Market

3. Needle-Free Delivery Technology: Global Market 2016-2026
3.1 The Needle-Free Delivery Technology Market: Overview
3.2 Needle-Free Delivery Technology Market Segmentation, 2016
3.3 The Needle-Free Delivery Technology Market Forecast, 2016-2026
3.4 How Will Segmental Market Shares Change to 2026?
3.5 Needle-Free Delivery Technology: Market Trends, 2016-2026
3.6 Needle-Free Delivery Technology: Drivers and Restraints 2016-2026

4. Jet Injectors Technology Market, 2016-2026
4.1 The Jet Injectors Market Overview
4.2 Jet Injectors: Market Forecast 2016-2026
4.3 Jet Injector Devices on the Market
4.3.1 Biojector 2000 (Bioject Medical Technologies)
4.3.2 ZetaJet (Bioject Medical Technologies)
4.3.3 Vision (Antares Pharma)
4.3.4 Vibex (Antares Pharma)
4.3.5 Sumavel DosePro (Endo International)
4.3.6 Stratis (PharmaJet)
4.3.7 LectraJet (D’Antonio Consultants International)
4.3.8 AdvantaJet and GentleJet (Activa Brand Products)
4.3.9 Vitajet (Bioject Medical Technologies)
4.3.10 Med-Jet (Medical International Technologies)
4.3.11 J-Tip (National Medical Products)
4.3.12 Injex30 (Injex Pharma)
4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak)
4.3.14 E-Jet 100 (Eurojet Medical)
4.3.15 Penjet (Penjet Corporation)
4.4 Jet Injectors Development Pipeline
4.4.1 Glide SDI (Glide Pharmaceutical Technologies)
4.4.2 Zeneo (Crossject)
4.4.3 Relday (Zogenix)
4.4.4 Magnetic Injection (Massachusetts Institute of Technology)
4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies)
4.4.6 Iject and Iject R (Bioject Medical Technologies)
4.4.7 Jupiter Jet (Bioject Medical Technologies)

5. Competing Needle-Free Technology Market, 2016-2026
5.1 The Competing Needle-Free Technology Overview
5.2 The Competing Technology: Market Forecast 2016-2026
5.3 How Will Segmental Market Shares Change to 2026?
5.4 Novel Needle Technology Overview
5.5 Novel Needle Technology: Market Forecast, 2016-2026
5.5.1 Leading Novel Needle Technologies
5.5.1.1 Soluvia Microinjection System (BD)
5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD)
5.5.1.3 AutoShield Duo Pen Needle (BD)
5.5.1.4 Microstructured Transdermal Systems (3M)
5.5.1.5 ZP Patch Technology (Zosano)
5.5.2 Novel Needle Technology Development Pipeline
5.5.2.1 Microneedle Patch (Georgia Institute of Technology)
5.5.2.2 Micronjet (NanoPass)
5.5.2.3 DebioJect (Debiotech)
5.5.2.4 AdminPen (nanoBioSciences)
5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp)
5.5.2.6 DrugMat and VaxMat (TheraJect)
5.5.2.7 MicroCor (Corium International)
5.5.2.8 Nanopatch (Vaxxas)
5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark)
5.5.2.10 Memspatch and Micro-Patch (Nemaura)
5.5.2.11 Microneedle Patch for Lidocaine Delivery (National University of Singapore)
5.6 Inhaler Technology Overview
5.7 Inhaler Technology: Market Forecast, 2016-2026
5.7.1 Inhaler Products in the Asthma Market
5.7.1.1 Preventer Inhalers
5.7.1.2 Reliever Inhalers
5.7.2 Inhaler Products in the Insulin Market
5.7.3 Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune)
5.7.3.1 Pipeline
5.8 Transdermal Patch Technology Overview
5.9 Transdermal Patch Technology: Market Forecast, 2016-2026
5.9.1 Selected Transdermal Patch Products
5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals)
5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline)
5.9.1.3 Exelon Patch (Rivastigmine, Novartis)
5.9.1.4 Zecuity (Sumatriptan, Teva)
5.9.2 Transdermal Patch Technology Development Pipeline
5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma)
5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems)
5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties)
5.9.2.4 Prelude SkinPrep System (Echo Therapeutics)
5.10 Other Competing Needle-free delivery Technology in development
5.10.1 Microbubbles Injection (Shibaura Institute of Technology)
5.10.2 Laser Injection (Seoul National University)
5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)

6. Leading National Markets 2016-2026
6.1 Global Needle-Free Delivery Technology Market: Regional Forecast 2016-2026
6.1.1 How Will Regional Market Shares Change to 2026?
6.2 The US Needle-Free Delivery Technology Market 2016-2026
6.2.1 US Needle-Free Delivery Technology Market Forecast 2016-2026
6.2.2 FDA Guideline for Combination Products
6.2.3 Needle-Free Delivery and the US Flu Vaccination Market
6.2.4 Measles Outbreak in the US
6.3 The EU5 Needle-Free Delivery Technology Market 2016-2026
6.3.1 EU5 Needle-Free Delivery Technology Market Forecast 2016-2026
6.3.2 The German Needle-Free Delivery Technology Market Forecast, 2016-2026
6.3.3 The French Needle-Free Delivery Technology Market Forecast, 2016-2026
6.3.4 The UK Needle-Free Delivery Technology Market Forecast, 2016-2026
6.3.5 The Italian Needle-Free Delivery Technology Market Forecast, 2015-2026
6.3.6 The Spanish Needle-Free Delivery Technology Market Forecast, 2016-2026
6.4 The Japanese Needle-Free Delivery Technology Market 2016-2026
6.4.1 Japanese Needle-Free Delivery Technology Market Forecast 2016-2026
6.5 The Chinese Needle-Free Delivery Technology Market 2016-2026
6.5.1 Chinese Needle-Free Delivery Technology Market Forecast 2016-2026
6.6 The Indian Needle-Free Delivery Technology Market 2016-2026
6.6.1 Indian Needle-Free Delivery Technology Market Forecast 2016-2026
6.6.2 Needles and Syringes being Reused in Indian Hospitals

7. Leading Companies in the Needle-Free Delivery Technology Market
7.1 Leading Needle-Free Delivery Technology Manufacturers in 2015
7.2 Antares Pharma: Leading the Needle-Free Injector Market
7.2.1 Antares Pharma: Needle-Free Technology Product Portfolio
7.2.2 Antares Pharma: Future Outlook
7.2.3 Antares Pharma: Products in Development
7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma
7.3 Zogenix
7.3.1 Zogenix: Product Portfolio
7.3.2 Zogenix: Current Pipeline
7.3.3 Zogenix: Financial Overview
7.4 3M: 50 Years of Drug Delivery Technology Development
7.4.1 3M: Drug Delivery Technology Portfolio
7.4.1.1 Oral and Topical Drug Delivery
7.4.1.2 MDI for Nasal and Inhalable Drugs
7.4.1.3 Transdermal patch Technology
7.4.1.4 Microneedle Technology
7.4.2 3M: Market Outlook
7.5 Becton Dickinson and Company (BD)
7.5.1 BD: Drug Delivery Technology Portfolio
7.5.1.1 Prefillable Syringe Systems
7.5.1.2 Self-Injection Systems
7.5.1.3 Pen Needles
7.5.1.4 Safety & Shielding Systems
7.5.2 BD: Future Outlook
7.5.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA
7.5.4 BD Acquired Injection Safety Firms
7.5.5 Recall of BD Needles in Hong Kong
7.6 PharmaJet
7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio
7.6.2 First FDA Approved Jet Injector for Flu Shot in the US
7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline
7.6.4 Preference for PharmaJet over Needle and Syringe
7.7 BioJect Medical Technologies
7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline
7.7.2 Bioject Medical Technologies: Financial Overview
7.7.3 Focusing on Developing Countries

8. Qualitative Analysis of the Needle-Free Delivery Technology Market
8.1 SWOT Analysis of the Needle-Free Delivery Technology Market
8.2 Strengths
8.2.1 Strong Growth in the Biologic Drug Market
8.2.2 Increasing Development in Transdermal Delivery
8.2.3 No Specialist Training Required and No Needlestick Injuries
8.2.4 Eliminating the Cold Chain Problem
8.3 Weaknesses
8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems
8.3.2 Greater Regulatory Scrutiny
8.3.3 Inefficient Manufacturing Processes
8.4 Opportunities
8.4.1 Emerging Economies Offer Significant Growth Opportunities
8.4.2 Mass Immunisation Programmes around the World
8.4.3 Increasing Global Diabetic Population
8.4.4 Shift towards Home Administration Setting
8.4.5 Extending Life Cycle of Drugs
8.5 Threats
8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
8.5.2 Needle and Syringes with Anti Needlestick Injury Technology
8.5.3 Limited Clinical Data
8.5.4 Medical Device Excise Tax

9. Conclusions
9.1 Current Leading Needle-Free Technology Segments
9.1.1 Notable Needle-Free Technology Companies
9.1.2 Leading Regional Markets
9.2 Global Needle-Free Technology Market Forecast 2015-2026
9.3 The Future of the Needle-Free Technology Market
9.3.1 Biosimilars are a Major Driver of the Needle-free Delivery Market
9.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market

10. Glossary

List of Tables
Table 2.1 Classification of Jet Injectors by Method of Propulsion
Table 2.2 Strengths and Weaknesses of the Jet Injector Market
Table 2.3 Pen Needle Technology by Needle Length
Table 2.4 Rationale for Needle-Free Vaccine Delivery
Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2016
Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016
Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2015
Table 2.8 Top 5 Biologics by Sales ($bn), 2015
Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015
Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 3.3 Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026
Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.2 Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015
Table 5.3 Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.4 Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.5 Leading Products in the Asthma Preventer Inhaler Market, 2016
Table 5.6 Leading Products in the Asthma Reliever Inhaler Market, 2016
Table 5.7 Vaccine Inhalers Currently Under Development, 2016
Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.9 Transdermal Patch Products, 2016
Table 6.1 Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026
Table 6.2 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
Table 6.3 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
Table 6.4 US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.5 EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.6 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026
Table 6.7 German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.8 French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.9 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026
Table 6.10 Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.11 Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.12 Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.13 Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026
Table 6.14 Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 7.1 Antares Pharma: Overview, 2016
Table 7.2 Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory
Table 7.3 Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015
Table 7.4 Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015
Table 7.5 Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.6 Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status)
Table 7.7 Zogenix: Overview, 2016
Table 7.8 Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.9 Zogenix: Revenue ($m) by Type, 2010-2015
Table 7.10 3M: Overview, 2016
Table 7.11 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
Table 7.12 BD: Overview, 2016
Table 7.13 BD: Drug Delivery Products by Segment, 2016
Table 7.14 BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
Table 7.15 BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015
Table 7.16 PharmaJet: Overview, 2016
Table 7.17 BioJect Medical Technologies: Overview, 2016
Table 7.18 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010
Table 7.19 Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026
Table 8.2 Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015

List of Figures
Figure 1.1 Global Needle-Free Delivery Technology Market Segmentation Overview, 2015
Figure 2.1 Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device
Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026
Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015
Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
Figure 4.1 The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026
Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026
Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015
Figure 5.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020
Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026
Figure 5.5 Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026
Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026
Figure 5.7 Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026
Figure 6.1 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026
Figure 6.2 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020
Figure 6.3 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026
Figure 6.4 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026
Figure 6.5 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015
Figure 6.6 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020
Figure 6.7 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026
Figure 6.8 US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
Figure 6.9 EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026
Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015
Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020
Figure 6.12 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026
Figure 6.13 German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
Figure 6.14 French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
Figure 6.15 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
Figure 6.16 Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026
Figure 6.17 Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 6.18 Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 6.19 Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 6.20 Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026
Figure 7.1 Antares Revenue from Major Customers: Revenue Share (%), 2014
Figure 7.2 Antares Revenue from Major Customers: Revenue Share (%), 2015
Figure 7.3 Antares Revenue by Region: Revenue Share (%), 2014
Figure 7.4 Antares Revenue by Region: Revenue Share (%), 2015
Figure 7.5 Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015
Figure 7.6 Zogenix: Revenue ($m) and AGR (%), 2010-2015
Figure 7.7 Zogenix: Revenue ($m) by Type, 2014
Figure 7.8 Zogenix: Revenue ($m) by Type, 2015
Figure 7.9 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015
Figure 7.10 BD: Historical Revenue ($bn) by Geographic Region, 2012-2015
Figure 7.11 BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015
Figure 7.12 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010
Figure 7.13 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014
Figure 8.1 The Transport Process for a Vaccine

★調査レポート[無針薬物送達技術の世界市場予測2016-2026]販売に関する免責事項
★調査レポート[無針薬物送達技術の世界市場予測2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆